Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 2/20 | 0.53 |
| ▸ | DGKA | P23743 | 1/20 | 0.51 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.49 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.49 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.49 |
| ▸ | FAAH | O00519 | 3/20 | 0.47 |
| ▸ | TERT | O14746 | 3/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.46 |
| ▸ | PPARG | P37231 | 3/20 | 0.46 |
| ▸ | PPARD | Q03181 | 3/20 | 0.46 |
| ▸ | PPARA | Q07869 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | BLM | P54132 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | GMNN | O75496 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL438671 | 1.00 | PRKCA (0.53) | PRKCADGKAPRKCEPRKCQPRKCD | |
| SCHEMBL9054604 | 0.92 | PRKCA (0.50) | PRKCAMAPTKMT2ALMNADUSP3 | |
| SCHEMBL9055070 | 0.92 | PRKCA (0.50) | PRKCAMAPTKMT2ALMNADUSP3 | |
| SCHEMBL4964792 | 0.89 | PRKCA (0.59) | PRKCADGKAPRKCEPRKCQPRKCD | |
| SCHEMBL9055293 | 0.89 | PRKCA (0.59) | PRKCADGKAPRKCEPRKCQPRKCD | |
| SCHEMBL9055938 | 0.89 | PRKCA (0.59) | PRKCADGKAPRKCEPRKCQPRKCD | |
| SCHEMBL1666730 | 0.89 | PRKCA (0.59) | PRKCADGKAPRKCEPRKCQPRKCD | |
| SCHEMBL9057567 | 0.89 | PRKCA (0.59) | PRKCADGKAPRKCEPRKCQPRKCD | |
| SCHEMBL6252306 | 0.89 | PRKCA (0.59) | PRKCADGKAPRKCEPRKCQPRKCD | |
| SCHEMBL8369299 | 0.88 | PRKCA (0.54) | PRKCADGKAPRKCEPRKCQPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011011065-A1 | METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE | MOAZED KAMBIZ THOMAS (US) | 2011-01-27 | — | — | WO | claimed |
| WO-1997004761-A1 | METHODS AND COMPOSITIONS FOR TREATING CELL PROLIFERATIVE DISORDERS | TRUSTEES OF BOSTON UNIVERSITY (US) | 1997-02-13 | — | — | WO | claimed |
| EP-0706369-A1 | STIMULATION OF TANNING BY DNA FRAGMENTS | TRUSTEES OF BOSTON UNIVERSITY (US) | 1996-04-17 | — | — | EP | claimed |
| WO-1996009810-A1 | METHODS FOR ENHANCING MELANIN SYNTHESIS IN MELANOCYTES USING DIACYLGLYCEROLS AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 1996-04-04 | — | — | WO | claimed |
| EP-0655907-A1 | USE OF DIACYLOLYCEROLS FOR INCREASING THE MELANIN CONTENT IN MELANOCYTES | TRUSTEES OF BOSTON UNIVERSITY (US) | 1995-06-07 | — | — | EP | claimed |
| WO-1995001773-A9 | STIMULATION OF TANNING BY DNA FRAGMENTS | — | 1995-02-16 | — | — | WO | claimed |
| WO-1995001773-A1 | STIMULATION OF TANNING BY DNA FRAGMENTS | TRUSTEES OF BOSTON UNIVERSITY (US) | 1995-01-19 | — | — | WO | claimed |
| WO-1994004122-A2 | USE OF DIACYLGLYCEROLS FOR INCREASING THE MELANIN CONTENT IN MELANOCYTES | TRUSTEES OF BOSTON UNIVERSITY (US) | 1994-03-03 | — | — | WO | claimed |
| EP-3501519-B1 | BRYOSTATIN 1 FOR USE IN TREATING IGE MEDIATED ALLERGIC DISEASES | NATIONAL UNIV CORPORATION NARA INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) | 2024-11-20 | — | — | EP | disclosed |
| WO-2023025899-A2 | DELIVERY SYSTEM FOR TARGETING GENES OF THE INTERFERON PATHWAY | TRANSGENE (FR) | 2023-03-02 | — | — | WO | disclosed |
| WO-2020225085-A1 | MEDIUM FOR GROWTH OF ORGANOIDS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2020-11-12 | — | — | WO | disclosed |
| EP-2549980-A2 | REVERSE MICELLE SYSTEM COMPRISING NUCLEIC ACIDS AND USE THEREOF | Medesis Pharma (FR) | 2013-01-30 | — | — | EP | disclosed |
| WO-2011117334-A2 | REVERSE MICELLE SYSTEM COMPRISING NUCLEIC ACIDS AND USE THEREOF | MEDESIS PHARMA (FR) | 2011-09-29 | — | — | WO | disclosed |
| WO-2011011065-A1 | METHOD AND SYSTEM FOR EFFECTING CHANGES IN PIGMENTED TISSUE | MOAZED KAMBIZ THOMAS (US) | 2011-01-27 | — | — | WO | disclosed |
| WO-1994014065-A1 | METHODS FOR IDENTIFYING AND USING IMMUNOSUPPRESSANT COMPOUNDS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 1994-06-23 | — | — | WO | disclosed |
| WO-1994004122-A2 | USE OF DIACYLGLYCEROLS FOR INCREASING THE MELANIN CONTENT IN MELANOCYTES | TRUSTEES OF BOSTON UNIVERSITY (US) | 1994-03-03 | — | — | WO | disclosed |
| WO-1992017151-A2 | METHOD OF ADMINISTERING DRUGS THROUGH MODIFICATION OF EPITHELIAL TIGHT JUNCTIONS BY TUMOR NECROSIS FACTOR | LANKENAU MEDICAL RESEARCH CENTER (US) | 1992-10-15 | — | — | WO | disclosed |
| EP-0362278-A4 | AUTOCRINE MOTILITY FACTORS IN CANCER DIAGNOSIS AND MANAGEMENT. | US HEALTH (US) | 1990-05-14 | — | — | EP | disclosed |
| EP-0362278-A1 | AUTOCRINE MOTILITY FACTORS IN CANCER DIAGNOSIS AND MANAGEMENT | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1990-04-11 | — | — | EP | disclosed |
| WO-1988009797-A1 | AUTOCRINE MOTILITY FACTORS IN CANCER DIAGNOSIS AND MANAGEMENT | THE UNITED STATES OF AMERICA, AS REPRESENTED BY TH (US) | 1988-12-15 | — | — | WO | disclosed |